Colon cancer transcriptome
K Mokhtari, M Peymani, M Rashidi… - Progress in biophysics …, 2023 - Elsevier
Over the last four decades, methodological innovations have continuously changed
transcriptome profiling. It is now feasible to sequence and quantify the transcriptional outputs …
transcriptome profiling. It is now feasible to sequence and quantify the transcriptional outputs …
Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages
Drug resistance is one of the significant clinical burden in renal cell carcinoma (RCC). The
development of drug resistance is attributed to many factors, including impairment of …
development of drug resistance is attributed to many factors, including impairment of …
[图书][B] Tumor multicomponent targeting polymer-lipid hybrid nanoparticles to overcome drug resistance in renal cell carcinoma
HO Alsaab - 2018 - search.proquest.com
Abstract Renal Cell Carcinoma (RCC) contributes to more than 90% of the most common
form of kidney tumor and remains one of the ten leading causes of cancer death in the …
form of kidney tumor and remains one of the ten leading causes of cancer death in the …